As such, in this manuscript, we set out to assess the expression of JADE2 in NSCLC to determine if its expression also had any potential utility as a biomarker in lung cancer at both the mRNA and protein levels. The gene discussed is JADE2; the disease is non-small cell lung carcinoma.